Order Center

Use the Order Center to build a Shopping Cart, view Saved Shopping Carts, Recent Orders and Quotes

MSDS

Search for MSDS (Material Safety Data Sheet) by Product Number

Oligo Ordering

Custom Products and Services, including DNA oligos (Primers and Probes), RNA, siRNA, Peptide Libraries and AQUA Peptides

Corporate

Sigma-Aldrich is a leading Life Science and High Technology Materials company focused on enabling science to improve the quality of life

Contact Us

Contact Customer Service

Web Toolbox

The Sigma-Aldrich Web Toolbox features helpful online science research tools and resources

New Email Subscription Center

To receive the information that is relevant to your work, explore our new subscription center and set your preferences

Request your 2013/15 Supelco Catalogue Today

Request your printed version of our NEW 2013/15 Supelco Catalogue - a must have technical resource for every chromatographer.

Monthly Savings

Discount savings on Analytical, Biology, Chemistry and Labware products

News & Information

St. Louis, MO - May 12, 2015 SAFC Expands Carlsbad, Calif. Facility to Support Commercial-Scale Gene Therapy Production, Testing and Filling

Sigma-Aldrich Corporation’s (NASDAQ: SIAL) custom manufacturing business unit, SAFC® Commercial (www.sigma-aldrich.com/safc), announced today the strategic expansion of its existing facility in Carlsbad, Calif. The investment will further enable SAFC to offer clinical and commercial bulk drug production, as well as fill/finish of viral products for its gene therapy, viral vaccine and immunotherapy customers.

Read More
St. Louis, MO - May 12, 2015 SAFC Completes ADC Commercial Manufacturing Capacity Expansion in St. Louis

Sigma-Aldrich® Corporation (NASDAQ: SIAL) today announced that SAFC® Commercial (www.sigma-aldrich.com/safc), its custom manufacturing services business unit, has completed the expansion of its St. Louis facility to support commercial-scale antibody drug conjugate (ADC) manufacturing. The facility is in final validation and expected to go online as planned in the third quarter of 2015. Once validated, customers will benefit from working with a single supplier from discovery to commercialization.

Read More
St. Louis, MO - May 6, 2015 Sigma-Aldrich Donates $50K in Products to the Reproducibility Project to Foster Replicable Research and Accelerate Scientific Discoveries in Cancer Biology

Donation is part of Sigma-Aldrich’s commitment to help translational researchers address irreproducibility in research, a growing industry concern

Sigma-Aldrich Corporation (NASDAQ: SIAL) today announced a $50,000 product donation to the Reproducibility Project: Cancer Biology, a large-scale initiative to replicate key findings from recent high-impact papers in the field of cancer biology. The project is a collaboration between the online research marketplace Science Exchange, the non-profit Center for Open Science and the open-access journal eLife.

Read More
St. Louis, MO - April 28, 2015 SAFC® Launches ADC Express℠ to Expedite Preclinical Antibody Drug Conjugation Services

Sigma-Aldrich Corporation today announced that SAFC Commercial (www.sigma-aldrich.com/safc), has introduced ADC Express preclinical development services within its Contract Manufacturing Services portfolio. This ADC (antibody drug conjugate) offering includes rapid preparation of development grade conjugate constructs for clients to use in their target molecule identification.

Read More